{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:10:40Z","timestamp":1791724240764,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s11060-025-04979-1","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T09:22:02Z","timestamp":1741771322000},"page":"289-296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Long-term impact of bevacizumab for the treatment of brain radiation necrosis"],"prefix":"10.1007","volume":"173","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5238-7373","authenticated-orcid":false,"given":"Hila","family":"Nobel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Ofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Faye","family":"Borenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dror","family":"Limon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Gal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosef","family":"Laviv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Kanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tali","family":"Siegal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomit","family":"Yust-Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Benouaich-Amiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"issue":"25","key":"4979_CR1","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.1200\/JCO.2005.03.145","volume":"23","author":"CJ Langer","year":"2005","unstructured":"Langer CJ, Mehta MP (2005) Current management of brain metastases, with a focus on systemic options. J Clin Oncol 23(25):6207\u20136219. https:\/\/doi.org\/10.1200\/JCO.2005.03.145","journal-title":"J Clin Oncol"},{"issue":"11","key":"4979_CR2","first-page":"4655","volume":"32","author":"E Tabouret","year":"2012","unstructured":"Tabouret E, Chinot O, Metellus P, Tallet A, Viens P, Gon\u00e7alves A (2012) Recent trends in epidemiology of brain metastases: an overview. Anticancer Res 32(11):4655\u20134662","journal-title":"Anticancer Res"},{"key":"4979_CR3","doi-asserted-by":"publisher","unstructured":"Khan M, Zhao Z, Arooj S, Liao G (2021) Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: A systematic review & meta-analysis. BMC Cancer. 2021;21(1):167. https:\/\/doi.org\/10.1186\/s12885-021-07889-3","DOI":"10.1186\/s12885-021-07889-3"},{"issue":"1","key":"4979_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijrobp.2023.07.015","volume":"118","author":"B Vellayappan","year":"2024","unstructured":"Vellayappan B, Lim-Fat MJ, Kotecha R, De Salles A, Fariselli L, Levivier M, Ma L, Paddick I, Pollock BE, Regis J, Sheehan JP, Suh JH, Yomo S, Sahgal A (2024) A systematic review informing the management of symptomatic brain radiation necrosis after stereotactic radiosurgery and International Stereotactic Radiosurgery Society recommendations. Int J Radiat Oncol Biol Phys 118(1):14\u201328. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.07.015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4979_CR5","doi-asserted-by":"publisher","unstructured":"Bernhardt D, K\u00f6nig L, Grosu A et al (2022) DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis. https:\/\/doi.org\/10.1007\/s00066-022-01994-3. Expert Panel of the German Society of Radiation Oncology (DEGRO)Strahlenther Onkol 198:873\u2014883","DOI":"10.1007\/s00066-022-01994-3"},{"issue":"2","key":"4979_CR6","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.21037\/apm-20-2417","volume":"10","author":"J Li","year":"2021","unstructured":"Li J, He J, Cai L, Lai M, Hu Q, Ren C, Wen L, Wang J, Zhou J, Zhou Z, Li S, Ye M, Shan C, Chen L, Zhou C (2021) Bevacizumab as a treatment for radiation necrosis following stereotactic radiosurgery for brain metastases: clinical and radiation dosimetric impacts. Ann Palliat Med 10(2):2018\u20132026. https:\/\/doi.org\/10.21037\/apm-20-2417","journal-title":"Ann Palliat Med"},{"key":"4979_CR7","doi-asserted-by":"publisher","first-page":"117556","DOI":"10.1016\/j.jns.2021.117556","volume":"427","author":"A Moore","year":"2021","unstructured":"Moore A, Yust-Katz S, Icht O, Eliyahou R, Gordon N, Cohen AY, Goldstein IM, Peled N, Seigal T, Amiel A, Dudnik E (2021) Bevacizumab for stereotactic radiosurgery-induced radiation necrosis in patients with non-small cell lung cancer treated with immune check-point inhibitors. J Neurol Sci 427:117556. https:\/\/doi.org\/10.1016\/j.jns.2021.117556","journal-title":"J Neurol Sci"},{"key":"4979_CR8","doi-asserted-by":"crossref","unstructured":"Med Mol Morphol (2015) 48:183\u2013190 Motomasa Furuse1 \u2022 Naosuke Nonoguchi1 \u2022 Shinji Kawabata1 \u2022 Shin-Ichi Miyatake1 \u2022 Toshihiko Kuroiwa1 delayed brain radiation necrosis. pathological review and new molecular targets for treatment","DOI":"10.1007\/s00795-015-0123-2"},{"key":"4979_CR9","doi-asserted-by":"crossref","unstructured":"Weng Y, Shen J, Zhang L, Fang Z, Xiao F, Zhang C, Fan Z, Huang K, Wang L, Huang B, Wu F, Zhang T, Xu Q Low-dosage bevacizumab treatment: effect on radiation necrosis after gamma knife radiosurgery for brain metastases. Front Surg 8:720506., van der Hopewell JW (2021) kogel AJ (1999) Pathophysiological mechanism leading to the development of late radiation-induced damage to the central nervous system. Front Radiat Ther Oncol 33;265\u2014275.","DOI":"10.3389\/fsurg.2021.720506"},{"issue":"2","key":"4979_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s11060-017-2442-8","volume":"133","author":"JM Kim","year":"2017","unstructured":"Kim JM, Miller JA, Kotecha R, Xiao R, Juloori A, Ward MC, Ahluwalia MS, Mohammadi AM, Peereboom DM, Murphy ES, Suh JH, Barnett GH, Vogelbaum MA, Angelov L, Stevens GH, Chao ST (2017) The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies. J Neurooncol 133(2):357\u2013368. https:\/\/doi.org\/10.1007\/s11060-017-2442-8","journal-title":"J Neurooncol"},{"issue":"4","key":"4979_CR11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.nec.2020.06.007","volume":"31","author":"D Lee","year":"2020","unstructured":"Lee D, Riestenberg RA, Haskell-Mendoza A, Bloch O (2020) Brain metastasis recurrence versus radiation necrosis: evaluation and treatment. Neurosurg Clin N Am 31(4):575\u2013587. https:\/\/doi.org\/10.1016\/j.nec.2020.06.007","journal-title":"Neurosurg Clin N Am"},{"issue":"2","key":"4979_CR12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11060-011-0610-9","volume":"105","author":"N Nonoguchi","year":"2011","unstructured":"Nonoguchi N, Miyatake S, Fukumoto M, Furuse M, Hiramatsu R, Kawabata S, Kuroiwa T, Tsuji M, Fukumoto M, Ono K (2011) The distribution of vascular endothelial growth factor-producing cells in clinical radiation necrosis of the brain: pathological consideration of their potential roles. J Neurooncol 105(2):423\u2013431. https:\/\/doi.org\/10.1007\/s11060-011-0610-9","journal-title":"J Neurooncol"},{"issue":"2","key":"4979_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10014-008-0233-9","volume":"25","author":"Y Yoshii","year":"2008","unstructured":"Yoshii Y (2008) Pathological review of late cerebral radionecrosis. Brain Tumor Pathol 25(2):51\u201358. https:\/\/doi.org\/10.1007\/s10014-008-0233-9","journal-title":"Brain Tumor Pathol"},{"key":"4979_CR14","doi-asserted-by":"publisher","first-page":"8447","DOI":"10.2147\/OTT.S223258","volume":"12","author":"H Zhuang","year":"2019","unstructured":"Zhuang H, Zhuang H, Shi S, Wang Y (2019) Ultra-low-dose bevacizumab for cerebral radiation necrosis: a prospective phase II clinical study. Onco Targets Ther 12:8447\u20138453. https:\/\/doi.org\/10.2147\/OTT.S223258","journal-title":"Onco Targets Ther"},{"key":"4979_CR15","doi-asserted-by":"publisher","first-page":"593449","DOI":"10.3389\/fonc.2021.593449","volume":"11","author":"G Liao","year":"2021","unstructured":"Liao G, Khan M, Zhao Z, Arooj S, Yan M, Li X (2021) Bevacizumab treatment of radiation-induced brain necrosis: a systematic review. Front Oncol 11:593449. https:\/\/doi.org\/10.3389\/fonc.2021.593449","journal-title":"Front Oncol"},{"issue":"3","key":"4979_CR16","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/COC.0b013e31829c3139","volume":"38","author":"NH Sadraei","year":"2015","unstructured":"Sadraei NH, Dahiya S, Chao ST, Murphy ES, Osei-Boateng K, Xie H, Suh JH, Peereboom DM, Stevens GH, Ahluwalia MS (2015) Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience. Am J Clin Oncol 38(3):304\u2013310. https:\/\/doi.org\/10.1097\/COC.0b013e31829c3139","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"4979_CR17","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.ijrobp.2009.12.061","volume":"79","author":"VA Levin","year":"2011","unstructured":"Levin VA, Bidaut L, Hou P, Kumar AJ, Wefel JS, Bekele BN, Grewal J, Prabhu S, Loghin M, Gilbert MR, Jackson EF (2011) Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys 79(5):1487\u20131495. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.12.061","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"4979_CR18","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1017\/cjn.2022.64","volume":"50","author":"SA Climans","year":"2023","unstructured":"Climans SA, Ramos RC, Jablonska PA, Shultz DB, Mason WP (2023) Bevacizumab for cerebral radionecrosis: a single-center experience. Can J Neurol Sci 50(4):573\u2013578. https:\/\/doi.org\/10.1017\/cjn.2022.64","journal-title":"Can J Neurol Sci"},{"issue":"6","key":"4979_CR19","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S1470-2045(15)70057-4","volume":"16","author":"NU Lin","year":"2015","unstructured":"Lin NU, Lee EQ, Aoyama H, Response Assessment in Neuro-Oncology (RANO) group et al (2015) Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol 16(6):e270\u2013e278. https:\/\/doi.org\/10.1016\/S1470-2045(15)70057-4","journal-title":"Lancet Oncol"},{"issue":"5","key":"4979_CR20","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1148\/rg.325125002","volume":"32","author":"R Shah","year":"2012","unstructured":"Shah R, Vattoth S, Jacob R, Manzil FF, O\u2019Malley JP, Borghei P, Patel BN, Cur\u00e9 JK (2012) Radiation necrosis in the brain: imaging features and differentiation from tumor recurrence. Radiographics 32(5):1343\u20131359. https:\/\/doi.org\/10.1148\/rg.325125002","journal-title":"Radiographics"},{"issue":"2","key":"4979_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ijrobp.2006.10.010","volume":"67","author":"J Gonzalez","year":"2007","unstructured":"Gonzalez J, Kumar AJ, Conrad CA, Levin VA (2007) Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys 67(2):323\u2013326. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.10.010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4979_CR22","doi-asserted-by":"publisher","first-page":"720506","DOI":"10.3389\/fsurg.2021.720506","volume":"8","author":"Y Weng","year":"2021","unstructured":"Weng Y, Shen J, Zhang L, Fang Z, Xiao F, Zhang C, Fan Z, Huang K, Wang L, Huang B, Wu F, Zhang T, Xu Q (2021) Low-dosage bevacizumab treatment: effect on radiation necrosis after gamma knife radiosurgery for brain metastases. Front Surg 8:720506. https:\/\/doi.org\/10.3389\/fsurg.2021.720506","journal-title":"Front Surg"},{"issue":"1","key":"4979_CR23","doi-asserted-by":"publisher","first-page":"220","DOI":"10.21037\/apm-20-2237","volume":"10","author":"M Lai","year":"2021","unstructured":"Lai M, Li S, Zhou J, Zhen J, Li J, Hu Q, Shan C, Ai R, Hong W, Wang H, Ye M, Yang Y, Xiao X, Wen L, Zhou Z, Zhou C, Cai L (2021) Stereotactic radiosurgery for treatment of large cerebellum metastases from lung cancer. Ann Palliat Med 10(1):220\u2013228. https:\/\/doi.org\/10.21037\/apm-20-2237","journal-title":"Ann Palliat Med"},{"issue":"2","key":"4979_CR24","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/cas.16053","volume":"115","author":"M Gao","year":"2024","unstructured":"Gao M, Wang X, Wang X, Niu G, Liu X, Zhao S, Wang Y, Yu H, Huo S, Su H, Song Y, Wang X, Zhuang HQ, Yuan ZY (2024) Can low-dose intravenous bevacizumab be as effective as high-dose bevacizumab for cerebral radiation necrosis? Cancer Sci 115(2):589\u2013599. https:\/\/doi.org\/10.1111\/cas.16053","journal-title":"Cancer Sci"},{"key":"4979_CR25","doi-asserted-by":"publisher","unstructured":"Yomo S, Hayashi M (2016) Salvage stereotactic radiosurgery with adjuvant use of bevacizumab for heavily treated recurrent brain metastases: a preliminary report. J Neurooncol 127, 119\u2013126. https:\/\/doi.org\/10.1007\/s11060-015-2019-3","DOI":"10.1007\/s11060-015-2019-3"},{"issue":"3","key":"4979_CR26","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s11060-013-1248-6","volume":"115","author":"AL Stockham","year":"2013","unstructured":"Stockham AL, Ahluwalia M, Reddy CA, Suh JH, Kumar A, Vogelbaum MA, Barnett GH, Murphy ES, Chao ST (2013) Results of a questionnaire regarding practice patterns for the diagnosis and treatment of intracranial radiation necrosis after SRS. J Neurooncol 115(3):469\u2013475. https:\/\/doi.org\/10.1007\/s11060-013-1248-6","journal-title":"J Neurooncol"},{"issue":"1","key":"4979_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12943-019-0950-1","volume":"18","author":"H Zhuang","year":"2019","unstructured":"Zhuang H, Shi S, Yuan Z, Chang JY (2019) Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues. Mol Cancer 18(1):21. https:\/\/doi.org\/10.1186\/s12943-019-0950-1","journal-title":"Mol Cancer"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-04979-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-04979-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-04979-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T08:45:00Z","timestamp":1748249100000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-04979-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["4979"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-04979-1","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"assertion":[{"value":"3 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board (RMC 0624\u2009\u2212\u200919) of Rabin Medical Center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The Institutional Review Board of Rabin Medical Center waived the need for informed patient consent due to the retrospective study design.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}